Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1 (2016)
Oliveira, Erica Aparecida de; Souza, Garcia Ferreira de; Lima, Diógenes Saulo de; Cardozo, Lucas Esteves; Faião-Flores, Fernanda; Suárez, José Agustín Pablo Quincoces; Nakaya, Helder Takashi Imoto 
; Monteiro, Gisele ; Maria-Engler, Silvya Stuchi
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Erica Aparecida de et al. Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2016APA
Oliveira, E. A. de, Souza, G. F. de, Lima, D. S. de, Cardozo, L. E., Faião-Flores, F., Suárez, J. A. P. Q., et al. (2016). Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Oliveira EA de, Souza GF de, Lima DS de, Cardozo LE, Faião-Flores F, Suárez JAPQ, Nakaya HTI, Monteiro G, Maria-Engler SS. Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 14 res. FCF024.[citado 2024 nov. 11 ]Vancouver
Oliveira EA de, Souza GF de, Lima DS de, Cardozo LE, Faião-Flores F, Suárez JAPQ, Nakaya HTI, Monteiro G, Maria-Engler SS. Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 14 res. FCF024.[citado 2024 nov. 11 ]
